10 April 2019
Biologists in Novosibirsk, in Siberia, have developed special nanoparticles that are said to be able to lower blood pressure, and are reported to have successfully tested the drug candidate on hypertension afflicted rats.
In a recent update Asya Levina, a researcher at the Novosibirsk State University (NSU), was quoted as saying that their solution is a system that consists of nanoparticles and short DNA molecules. “The former help the latter enter cells and bond with messenger ribonucleic acid (mRNA), thus preventing protein from forming. That results in no increase in the number of receptors on the cells, and the patient does not develop arterial hypertension.”
Reports by the World Health Organization (WHO) list cardiovascular diseases, including infarcts, strokes and chronic heart failures, as the number one natural killer globally. The diseases claim about 17 million people each year, and most of the victims hit their death road by developing chronic high blood pressure.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024